Menu

Ligand Pharmaceuticals Incorporated LGND

Full chart Compare
Set alert

Price alert · LGND

All alert types
314.16 USD +0.01 (+0.00%)

At closeNov 10, 2026, 4:00 PM EST

314.16 0.00 0.00%

After hours · Nov 10, 4:00 PM ET

310.41 Day range 321.98
175.89 52-week range 326.63
YTD
+66.16%
1 year
+50.11%

Revenue & Expenses

Other Income → Gross Profit & Other Income: $111.76MGross Profit & Other Income → Net Income: $124.45MGross Profit & Other Income → Selling, General & Admin: $92.45MGross Profit & Other Income → Research & Development: $81.18MGross Profit & Other Income → Other Operating Expenses: $40.67MGross Profit & Other Income → Income Tax: $34.51MGross Profit → Gross Profit & Other Income: $261.50MRevenue → Gross Profit: $261.50MRevenue → Cost of Revenue: $6.59MOther Income$111.76MGross Profit$261.50MCost of Revenue$6.59MGross Profit & Other Income$373.26MNet Income$124.45MSelling, General & Admin$92.45MResearch & Development$81.18MOther Operating Expenses$40.67MIncome Tax$34.51MRevenue$268.09M

Latest period ending Dec 31, 2025 · select a line to chart its full history

Annual income statement

LGND annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
268.09M167.13M131.31M196.25M241.54M
268.09M167.13M131.31M196.25M241.54M
14.55M11.07M10.51M52.83M62.18M
253.54M156.06M120.80M143.42M179.37M
212.54M178.66M108.86M140.38M75.52M
81.18M21.43M24.54M36.08M32.10M
92.45M78.65M52.79M70.06M46.79M
41.00M-22.61M11.94M3.04M103.85M
4.71M3.04M656.00K1.80M19.62M
34.51M6.55M9.84M41.23M-4.15M
124.45M-4.03M52.15M-33.36M57.14M
124.45M-4.03M52.15M-33.36M57.14M
124.45M-4.03M52.15M-33.36M57.14M
124.45M-4.03M52.15M-33.36M57.14M
6.44-0.223.02-1.983.44
6.44-0.223.02-1.983.44
6.13-0.222.94-1.983.31
163.68M5.55M62.65M9.67M72.61M
163.68M5.55M62.65M9.67M72.61M
19.34M18.29M17.30M16.87M16.63M
20.29M18.29M17.76M16.87M17.25M